Imunon, Inc. (IMNN) Financials

IMNN Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 8.0 million 4.7 million
Dec. 31, 2025 12.3 million 5.2 million
Sept. 30, 2025 9.0 million 4.9 million
June 30, 2025 8.8 million 6.1 million

IMNN Free Cash Flow and Stock based compensation

No data available :(

IMNN Net Income

No data available :(

IMNN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.8 million - 492849
Dec. 31, 2025 8.8 million - 1.0 million
Sept. 30, 2025 5.3 million - 1.1 million
June 30, 2025 4.7 million - 1.2 million

IMNN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 5.0 million
Dec. 31, 2025 2.1 million
Sept. 30, 2025 2.9 million
June 30, 2025 1.5 million

IMNN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4 2.3 million 2.0 billion -
Dec. 31, 2025 3589 2.5 million 1.8 million -
Sept. 30, 2025 3 1.9 million 1.6 million -
June 30, 2025 17331 1.2 million 1.5 million -

IMNN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 166544
Dec. 31, 2025 -725202 169265
Sept. 30, 2025 - 167034
June 30, 2025 - 164674

IMNN

Price: $1.82

52 week price:
1.82
27.65

Earnings Per Share: -4.52 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.2 million

Links: